Abstract:Background Pulmonary arterial hypertension (PAH) is a progressive and devastating disease characterized by pulmonary vascular remodeling which is associated with the malignant phenotypes of pulmonary vascular cells. Recently, the effects of heat shock protein 110 (Hsp110) in human arterial smooth muscle cells were reported. However, the underlying roles and mechanisms of Hsp110 in human pulmonary arterial endothelial cells (HPAECs) that was disordered firstly at the early stage of PAH remain unknown. Methods In this research, the expression of Hsp110 in PAH human patients and rat models was investigated, and the Hsp110 localization was determined both in vivo and in vitro. The roles and mechanism of elevated Hsp110 in excessive cell proliferation and migration of HPAECs were assessed respectively exposed to hypoxia. Small molecule inhibitors targeting Hsp110-STAT3 interaction were screened via fluorescence polarization, anti-aggregation and western blot assays. Moreover, the effects of compound 6 on HPAECs abnormal phenotypes in vitro and pulmonary vascular remodeling of hypoxia-indued PAH rats in vivo by interrupting Hsp110-STAT3 interaction were evaluated. Results Our studies demonstrated that Hsp110 expression was increased in the serum of patients with PAH, as well as in the lungs and pulmonary arteries of PAH rats, when compared to their respective healthy subjects. Moreover, Hsp110 levels were significantly elevated in HPAECs under hypoxia and mediated its aberrant phenotypes. Furthermore, boosted Hsp110-STAT3 interaction resulted in abnormal proliferation and migration via elevating p-STAT3 and c-Myc in HPAECs. Notably, we successfully identified compound 6 as potent Hsp110-STAT3 interaction inhibitor, which effectively inhibited HPAECs proliferation and migration, and significantly ameliorated right heart hypertrophy and vascular remodeling of rats with PAH. Conclusions Our studies suggest that elevated Hsp110 plays a vital role in HPAECs and inhibition of the Hsp110-STAT3 interaction is a novel strategy for improving vascular remodeling. In addition, compound 6 could serve as a promising lead compound for developing first-in-class drugs against PAH.

Inhibition of RhoA/ROCK Signaling Pathway Ameliorates Hypoxic Pulmonary Hypertension Via HIF-1α-dependent Functional TRPC Channels

Role of Rho-kinase and Its Inhibitors in Pulmonary Hypertension

The role of RhoA/ROCK pathway in the rat models of left heart disease-associated pulmonary hypertension

Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats.

Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1/STAT3 signaling pathway

Atorvastatin Attenuates Involvement of RhoA/Rho-kinase Pathway and NF-κB Activation in Hypoxic Pulmonary Hypertensive Rats

HIF‐1α Promotes the Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells Via Activation of Cx43

Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p‐JNK MAPK pathway

PD-1/PD-L1 Provides Protective Role in Hypoxia-Induced Pulmonary Vascular Remodeling

Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.

HMGB1/TLR4 Promotes Hypoxic Pulmonary Hypertension Via Suppressing BMPR2 Signaling.

A Critical Role of the Mtor/eif2α Pathway in Hypoxia-Induced Pulmonary Hypertension

Kappa-Opioid Receptor Stimulation Improves Endothelial Function In Hypoxic Pulmonary Hypertension

Inhibition of Hsp110-STAT3 Interaction in Endothelial Cells Alleviates Vascular Remodeling in Hypoxic Pulmonary Arterial Hypertension Model

Role of the G-protein and tyrosine kinase--Rho/ROK pathways in 15-hydroxyeicosatetraenoic acid induced pulmonary vasoconstriction in hypoxic rats.

Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.

Mice Lacking 1,4,5-Triphosphate Inositol Type III Receptor Demonstrate Inhibition of Hypoxic Pulmonary Hypertension

Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs

Classical Transient Receptor Potential 1 and 6 Contribute to Hypoxic Pulmonary Hypertension Through Differential Regulation of Pulmonary Vascular Functions

Lycopene Ameliorates Hypoxic Pulmonary Hypertension via Suppression of Oxidative Stress

C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats